Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400995

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400995

Liver Disease Treatment Market, by Treatment Type, Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

PUBLISHED:
PAGES: 266 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Liver Disease Treatment market size was valued at USD 22,300.42 Million in 2022, expanding at a CAGR of 6.42% from 2023 to 2030.

Treatment for liver disease refers to medical measures taken to control and lessen illnesses that have an impact on the structure or operation of the liver. Depending on the exact liver ailment, several treatment modalities are used, but they often entail modifying one's lifestyle, taking medications, and in extreme circumstances, undergoing surgery or a liver transplant. Hepatitis, cirrhosis, fatty liver disease, and liver cancer are examples of common liver illnesses. Controlling inflammation, treating symptoms, avoiding consequences, and addressing underlying causes are frequently the objectives of treatment. To improve results and maintain liver function, early diagnosis, and prompt treatments are essential.

Liver Disease Treatment Market Dynamics

The rise in the number of people with liver diseases propelled the market growth

The increased prevalence of liver disorders, the rise in alcohol usage, and poor eating habits are the main factors anticipated to propel growth in the market for therapies for liver diseases. For instance, according to a research report that was published in the Clinical Liver Disease journal in June 2021, chronic liver disease (CLD), which affects nearly 1.5 billion people worldwide, is one of the major causes of sickness and mortality globally. Furthermore, according to research published in June 2021 by the American Association for the Study of Liver Diseases, non-alcoholic fatty liver disease (NAFLD) is the leading cause of hepatic illness, accounting for 59% of cases, followed by hepatitis C (9%), hepatitis B (29%), and alcoholic liver disease (ALD) (2%). Furthermore, a research published in Clinical and Molecular Hepatology in October 2022 predicted that by 2040, the prevalence of non-alcoholic fatty liver disease (NAFLD) will be 55.7% worldwide. As a result, rising liver ailments have fueled the industry as a whole.

Liver Disease Treatment Market- Key Insights

As per the analysis shared by our research analyst, the Global Liver Disease Treatment market is estimated to grow annually at a CAGR of around 6.42% over the forecast period (2023-2030)

The Liver Disease Treatment market is projected to grow at a significant rate due to the rise in the number of people with liver diseases to propel the market growth

Based on Treatment Type segmentation, Antiviral Drugs was predicted to show maximum market share in the year 2022

Based on Disease Type segmentation, Hepatitis was the leading Disease Type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Liver Disease Treatment Market- Segmentation Analysis:

The Global Liver Disease Treatment market is segmented on the basis of Treatment Type, Disease Type, and Region.

The market is divided into categories based on Treatment Type: Immunosuppressants, Antiviral Drugs, Immunoglobulins, Vaccines, Targeted Therapy, Corticosteroids, and Chemotherapy Drugs. Positive effects are being produced on the antiviral drug's sub-segment by the significantly increasing expenditures in the sector, largely because of its numerous advantages. Additionally, rising healthcare costs, increased public awareness, and an increase in the prevalence of hepatitis B and C are other significant aspects anticipated to support market expansion.

The market is divided into categories based on Disease Type: Autoimmune Diseases, Hepatitis, Non-alcoholic Fatty Liver Disease (NAFLD), Genetic Disorders, Cancer, and Others. Due to pharmaceutical mistakes, excessive alcohol intake, autoimmune disorders, viral infections, and nonalcoholic steatohepatitis, the inflammatory status of the liver tissue has significantly worsened during the past several years.

Liver Disease Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America region is expected to grow. In 2022, the market for Liver Disease Treatments will be dominated by North America. The extensively increasing need for advanced and innovative liver disease therapeutics particularly in China, India, and South Korea is one of the key elements boosting the development of the industry. Also, one of the major factors behind this growth can be the increasing prevalence of NAFLD and hepatitis, lack of expertise, and the poor healthcare infrastructure in the region.

Liver Disease Treatment Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary Types used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in January 2023, Topline data from the Phase 2 SEQUOIA clinical research of experimental Fazirsiran for the treatment of liver disease linked to alpha-1 antitrypsin deficiency (AATD-LD) were released by Takeda and Arrowhead Pharmaceuticals Inc.

Recent Developments:

In June 2023, according to Ipsen, individuals with Alagille syndrome (ALGS) starting at 12 months of age can now treat their cholestatic pruritus with Bylvay® (odevixibat), as to an FDA approval. Bylvay is a once-daily, minimally systemically exposed, locally acting ileal bile acid transport inhibitor (IBATi) with minimum systemic exposure. In the United States and Europe, Bylvay was authorized as the first medication for treating cholestatic pruritus in individuals with progressive familial intrahepatic cholestasis (PFIC) in 2021. For qualifying ALGS patients, Bylvay is instantly available with a prescription.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVER DISEASE TREATMENT MARKET KEY PLAYERS

  • Vertex Pharmaceuticals
  • Takeda Pharmaceuticals
  • Shire (now part of Takeda Pharmaceuticals)
  • Roche
  • Pfizer
  • Novartis
  • Madrigal Pharmaceuticals
  • Intercept Pharmaceuticals
  • Gilead Sciences
  • Genfit
  • Durect Corporation
  • Conatus Pharmaceuticals
  • Bristol-Myers Squibb
  • Alnylam Pharmaceuticals
  • Allergan

GLOBAL LIVER DISEASE TREATMENT MARKET, BY TREATMENT TYPE

  • Immunosuppressants
  • Antiviral Drugs
  • Immunoglobulins
  • Vaccines
  • Targeted Therapy
  • Corticosteroids
  • Chemotherapy Drugs

GLOBAL LIVER DISEASE TREATMENT MARKET, BY DISEASE TYPE

  • Autoimmune Diseases
  • Hepatitis
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Genetic Disorders
  • Cancer
  • Others

GLOBAL LIVER DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV1959

Table of Contents

1. Liver Disease Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Liver Disease Treatment Market Snippet by Treatment Type
    • 2.1.2. Liver Disease Treatment Market Snippet by Disease Type
    • 2.1.3. Liver Disease Treatment Market Snippet by Country
    • 2.1.4. Liver Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Semiconductor Memory Key Market Trends

  • 3.1. Liver Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Liver Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Liver Disease Treatment Market Opportunities
  • 3.4. Liver Disease Treatment Market Future Trends

4. Semiconductor Memory Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Liver Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Liver Disease Treatment Market Landscape

  • 6.1. Liver Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Liver Disease Treatment Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
    • 7.1.2. Immunosuppressants
    • 7.1.3. Antiviral Drugs
    • 7.1.4. Immunoglobulins
    • 7.1.5. Vaccines
    • 7.1.6. Targeted Therapy
    • 7.1.7. Corticosteroids
    • 7.1.8. Chemotherapy Drugs

8. Liver Disease Treatment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Autoimmune Diseases
    • 8.1.3. Hepatitis
    • 8.1.4. Non-alcoholic Fatty Liver Disease (NAFLD)
    • 8.1.5. Genetic Disorders
    • 8.1.6. Cancer
    • 8.1.7. Others

9. Liver Disease Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Semiconductor Memory Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Semiconductor Memory Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Semiconductor Memory Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Semiconductor Memory Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Semiconductor Memory Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Semiconductor Memory Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Vertex Pharmaceuticals
    • 10.2.2. Takeda Pharmaceuticals
    • 10.2.3. Shire (now part of Takeda Pharmaceuticals)
    • 10.2.4. Roche
    • 10.2.5. Pfizer
    • 10.2.6. Novartis
    • 10.2.7. Madrigal Pharmaceuticals
    • 10.2.8. Intercept Pharmaceuticals
    • 10.2.9. Gilead Sciences
    • 10.2.10. Genfit
    • 10.2.11. Durect Corporation
    • 10.2.12. Conatus Pharmaceuticals
    • 10.2.13. Bristol-Myers Squibb
    • 10.2.14. Alnylam Pharmaceuticals
    • 10.2.15. Allergan

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
Product Code: ANV1959

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liver Disease Treatment Market: Treatment Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Liver Disease Treatment Market, by Treatment Type 2018-2030 (USD Million)
  • TABLE Liver Disease Treatment Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Liver Disease Treatment Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Liver Disease Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liver Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)

List of Figures

  • FIGURE Liver Disease Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Treatment Type segment market share analysis, 2022 & 2030
  • FIGURE Treatment Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Type segment market share analysis, 2022 & 2030
  • FIGURE Disease Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Europe Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Latin America Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Liver Disease Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Germany Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE India Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Brazil Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!